← Back to Analyst Consensus 
BOLD Hold
Boundless Bio, Inc.
Current Price —
Implied Upside —
Analysts 6
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 3, 2026 (8 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 11, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $4 | 44% |
| Jun 2, 2025 | HC Wainwright & Co. | initiate | — → Buy | $5 | 44% |
| May 28, 2025 | Leerink Partners | downgrade | Outperform → Market Perform | $3 | 51% |
| Dec 13, 2024 | Guggenheim | downgrade | Buy → Neutral | $0 | 52% |
| Apr 22, 2024 | Leerink Partners | initiate | — → Outperform | $25 | 51% |
| Apr 22, 2024 | Guggenheim | initiate | — → Buy | $24 | 52% |
| Apr 22, 2024 | Piper Sandler | initiate | — → Overweight | $20 | 54% |
Price Target Trend
May 1, 2026 Oct 26, 2026
EPS Estimates
0y —
0q —
+1q —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days